Polymyxin B – Injection products
Exception to the recognized standard of CLSI M100
For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:
Acinetobacter spp.
Enterobacteriaceae
Pseudomonas aeruginosa
On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.